Abstract: Provided are a time and frequency control method and system for optical comb. The method includes: controlling an optical comb measuring system to start and to generate an optical comb; obtaining monitoring data, wherein the monitoring data comprises a working temperature, a mode-locked frequency and a light pump power, wherein the mode-locked frequency comprises a repetition frequency and a carrier envelope phase locked at the end of starting the optical comb measuring system; determining whether an offset of the mode-locked frequency exceeds a self-feedback adjustment range of a hardware adjustment circuit; and in response to any of the repetition frequency and the carrier envelope phase exceeds the self-feedback adjustment range, adjusting the working temperature and the light pump power until the mode-locked frequency returns back into the self-feedback adjustment range.

Abstract: Disclosed is a tumor treatment method, wherein immune effector cells and Gemcitabine are administered to an individual with tumor, and the immune effector cells express receptors having a tumor-specific antigen. Also disclosed is a tumor treatment kit, wherein the kit comprises 1) immune effector cells expressing receptors that recognize tumor antigens; 2) Gemcitabine; 3) a container for containing the substances of 1) and 2) described above; and 4) drug administration instructions for using the kit to treat a tumor.

Abstract: Provided are a time and frequency control method and system for optical comb. The method includes: controlling an optical comb measuring system to start and to generate an optical comb; obtaining monitoring data, wherein the monitoring data comprises a working temperature, a mode-locked frequency and a light pump power, wherein the mode-locked frequency comprises a repetition frequency and a carrier envelope phase locked at the end of starting the optical comb measuring system; determining whether an offset of the mode-locked frequency exceeds a self-feedback adjustment range of a hardware adjustment circuit; and in response to any of the repetition frequency and the carrier envelope phase exceeds the self-feedback adjustment range, adjusting the working temperature and the light pump power until the mode-locked frequency returns back into the self-feedback adjustment range.

Abstract: Provided in the present invention is a method for treating tumor. An immune effector cell and a second treatment agent are applied to individual suffering from tumor, wherein the immune effector cell expresses a receptor for recognizing tumor antigen, and wherein the second treatment agent is a compound of formula I or a pharmaceutically acceptable salt thereof.

Abstract: Provided are a fusion protein comprising an antibody binding area and an endocytic functional area, the encoding nucleic acid of the protein, an expression vector of same, a host cell thereof, and an immune effector cell expressing the fusion protein or the endocytic functional area or further expressing a chimeric antigen receptors. Also provided are an immunoconjugate comprising a cell-killing part and an antibody conjugate in a specifically-binding immune effector cell or an antibody of the endocytic functional area, a reagent kit and uses of the immunoconjugate, and a method for specifically removing, selecting, or enriching and detecting the immune effector cell.